A new study has found that anti-estrogen medications can prevent the recurrence of breast cancer in some women.
Aromasin is the name of the drug, according to Health Day. It belongs to a class of drugs called aromatase inhibitors and it has reduced the risk of recurrence among breast cancer patients.
“For years, tamoxifen has been the standard hormone therapy for preventing breast cancer recurrences in young women with hormone-sensitive disease. These results confirm that exemestane with ovarian function suppression constitutes a valid alternative,” study lead author Dr. Olivia Pagani.